SHPH Projected Dividend Yield
Shuttle Pharmaceuticals Holdings Inc ( NASDAQ : SHPH )Shuttle Pharmaceuticals Holdings is a clinical stage pharmaceutical company utilizing its proprietary technology to develop therapies designed to cure cancers. Co. is developing a pipeline of products designed to address limitations of the existing cancer therapies as well as to extend to the new applications of radiation therapy (RT). Co.'s product candidates include Ropidoxuridine (IPdR), Extended Bio-availability IPdR, and a platform of histone deacetylase inhibitors (SP-1-161, SP-2-225 and SP-1-303). IPdR is Co.'s primary candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. 20 YEAR PERFORMANCE RESULTS |
SHPH Dividend History Detail SHPH Dividend News SHPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |